Prenatal maternal phthalate exposures and child lipid and adipokine levels at age six: A study from the PROGRESS cohort of Mexico City.


Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
01 2021
Historique:
received: 09 07 2020
revised: 30 09 2020
accepted: 11 10 2020
pubmed: 18 10 2020
medline: 20 4 2021
entrez: 17 10 2020
Statut: ppublish

Résumé

Prenatal phthalate exposures may affect processes that underlie offspring cardiometabolic health, but findings from studies examining these associations are conflicting. We examined associations between biomarkers of phthalate exposures during pregnancy with child lipid and adipokine levels. Data were from 463 mother-child pairs in the PROGRESS cohort of Mexico City. We quantified 15 phthalate metabolites in 2nd and 3rd trimester maternal urine samples and created an average pregnancy measure using the geometric mean. We evaluated the 15 metabolites as nine biomarkers, including four metabolite molar sums. We measured fasting serum triglycerides, non-HDL cholesterol, leptin, and adiponectin in children at the six-year follow-up visit (mean = 6.8 years). We estimated associations using linear regression, Bayesian kernel machine regression (BKMR), and weighted quantile sum (WQS) and assessed effect modification by sex. In BKMR and WQS models, higher concentrations of the total mixture of phthalate biomarkers were associated with lower triglycerides (β = -3.7% [-6.5, -0.78] per 1 unit increase in WQS biomarker index) and non-HDL cholesterol (β = -2.0 [-3.7, -0.25] ng/ml per increase in WQS biomarker index). Associations between individual biomarkers and child outcomes were largely null. We observed some evidence of effect modification by child sex for mono-3-carboxypropyl phthalate (β = 19.4% [1.26, 40.7] per doubling of phthalate) and monobenzyl phthalate (β = -7.6% [-14.4, -0.23]) in girls for adiponectin. Individual prenatal phthalate biomarkers were not associated with child lipid or adipokine levels. Contrary to our hypothesis, the total phthalate mixture was associated with lower child triglycerides and non-HDL cholesterol.

Sections du résumé

BACKGROUND
Prenatal phthalate exposures may affect processes that underlie offspring cardiometabolic health, but findings from studies examining these associations are conflicting. We examined associations between biomarkers of phthalate exposures during pregnancy with child lipid and adipokine levels.
METHODS
Data were from 463 mother-child pairs in the PROGRESS cohort of Mexico City. We quantified 15 phthalate metabolites in 2nd and 3rd trimester maternal urine samples and created an average pregnancy measure using the geometric mean. We evaluated the 15 metabolites as nine biomarkers, including four metabolite molar sums. We measured fasting serum triglycerides, non-HDL cholesterol, leptin, and adiponectin in children at the six-year follow-up visit (mean = 6.8 years). We estimated associations using linear regression, Bayesian kernel machine regression (BKMR), and weighted quantile sum (WQS) and assessed effect modification by sex.
RESULTS
In BKMR and WQS models, higher concentrations of the total mixture of phthalate biomarkers were associated with lower triglycerides (β = -3.7% [-6.5, -0.78] per 1 unit increase in WQS biomarker index) and non-HDL cholesterol (β = -2.0 [-3.7, -0.25] ng/ml per increase in WQS biomarker index). Associations between individual biomarkers and child outcomes were largely null. We observed some evidence of effect modification by child sex for mono-3-carboxypropyl phthalate (β = 19.4% [1.26, 40.7] per doubling of phthalate) and monobenzyl phthalate (β = -7.6% [-14.4, -0.23]) in girls for adiponectin.
CONCLUSIONS
Individual prenatal phthalate biomarkers were not associated with child lipid or adipokine levels. Contrary to our hypothesis, the total phthalate mixture was associated with lower child triglycerides and non-HDL cholesterol.

Identifiants

pubmed: 33068586
pii: S0013-9351(20)31238-X
doi: 10.1016/j.envres.2020.110341
pmc: PMC7736226
mid: NIHMS1637934
pii:
doi:

Substances chimiques

Adipokines 0
Environmental Pollutants 0
Lipids 0
Phthalic Acids 0
phthalic acid 6O7F7IX66E

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110341

Subventions

Organisme : NIEHS NIH HHS
ID : R01 ES021357
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES013744
Pays : United States
Organisme : NIEHS NIH HHS
ID : R24 ES028522
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES023515
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES028805
Pays : United States
Organisme : NIEHS NIH HHS
ID : R00 ES023450
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES009089
Pays : United States
Organisme : NIEHS NIH HHS
ID : R00 ES023474
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES024381
Pays : United States

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Front Public Health. 2018 Nov 27;6:327
pubmed: 30538977
Environ Health. 2014 Jun 10;13(1):50
pubmed: 24916609
Toxicology. 2019 Mar 1;415:49-55
pubmed: 30660623
PLoS One. 2013;8(2):e56800
pubmed: 23437242
Biostatistics. 2015 Jul;16(3):493-508
pubmed: 25532525
Regul Toxicol Pharmacol. 2006 Jul;45(2):169-77
pubmed: 16750591
Environ Int. 2014 Jan;62:1-11
pubmed: 24161445
Toxicol Lett. 2009 Aug 25;189(1):67-77
pubmed: 19463926
Diabetes. 2003 Jul;52(7):1655-63
pubmed: 12829629
Risk Anal. 2006 Jun;26(3):803-24
pubmed: 16834635
Environ Int. 2016 Dec;97:212-236
pubmed: 27669632
Toxicology. 2008 Sep 4;250(2-3):75-81
pubmed: 18602967
Chemosphere. 2017 Dec;188:174-181
pubmed: 28886551
Front Endocrinol (Lausanne). 2018 Sep 03;9:511
pubmed: 30233497
Am J Epidemiol. 2006 Feb 15;163(4):374-83
pubmed: 16394206
Environ Toxicol Pharmacol. 2006 Jan;21(1):93-102
pubmed: 21783644
J Biol Chem. 1997 Feb 21;272(8):5283-90
pubmed: 9030601
Environ Health Perspect. 2016 Apr;124(4):507-13
pubmed: 26308089
Environ Int. 2018 Apr;113:231-239
pubmed: 29453090
Environ Sci Technol. 2020 Feb 4;54(3):1740-1749
pubmed: 31944681
Environ Int. 2014 Jul;68:55-65
pubmed: 24709781
Epidemiology. 2016 May;27(3):449-58
pubmed: 26745610
Lipids. 1987 Aug;22(8):572-7
pubmed: 3657395
J Clin Endocrinol Metab. 2016 Jan;101(1):79-88
pubmed: 26529628
MethodsX. 2019 Nov 22;6:2855-2860
pubmed: 31871919
Pediatrics. 2006 Jul;118(1):201-6
pubmed: 16818566
Environ Res. 2017 Apr;154:311-317
pubmed: 28152472
PLoS One. 2015 Dec 02;10(12):e0143190
pubmed: 26630026
Environ Int. 2015 Dec;85:27-39
pubmed: 26313703
Environ Res. 2019 Feb;169:26-32
pubmed: 30408750
Int J Obes Relat Metab Disord. 2000 Dec;24(12):1653-9
pubmed: 11126220
Epigenomics. 2013 Jun;5(3):271-81
pubmed: 23750643
Pediatr Res. 2007 Jun;61(6):640-5
pubmed: 17426657
Environ Health. 2014 Oct 22;13:84
pubmed: 25336252
Nat Rev Endocrinol. 2017 Mar;13(3):161-173
pubmed: 27857130
J Agric Biol Environ Stat. 2015 Mar;20(1):100-120
pubmed: 30505142
Arch Environ Contam Toxicol. 2009 Nov;57(4):777-84
pubmed: 19330368
Environ Int. 2019 Feb;123:325-336
pubmed: 30557812
Environ Health. 2019 Aug 28;18(1):76
pubmed: 31462251
Toxicol In Vitro. 2015 Dec 25;30(1 Pt B):383-93
pubmed: 26423653
Toxicol Lett. 2009 Dec 1;191(1):9-14
pubmed: 19643168
Environ Health Perspect. 2017 Sep 11;125(9):097008
pubmed: 28935615
Mt Sinai J Med. 2011 Jan-Feb;78(1):22-48
pubmed: 21259261
Am J Hum Biol. 1999;11(2):259-266
pubmed: 11533949
Environ Health Perspect. 2010 Apr;118(4):539-44
pubmed: 20368132
Environ Health Perspect. 2012 Jun;120(6):779-89
pubmed: 22296744
Environ Health Perspect. 2005 Nov;113(11):1530-5
pubmed: 16263507
Curr Environ Health Rep. 2019 Jun;6(2):53-61
pubmed: 31069725
Mol Cell Endocrinol. 2009 May 25;304(1-2):19-29
pubmed: 19433244
Endocrinology. 2003 Jan;144(1):101-9
pubmed: 12488335
Biochem Biophys Res Commun. 2003 Feb 21;301(4):1045-50
pubmed: 12589818
Mol Metab. 2018 Sep;15:45-55
pubmed: 29858147
Pediatrics. 2008 Jul;122(1):198-208
pubmed: 18596007
Environ Health Perspect. 2012 May;120(5):739-45
pubmed: 22262702
Diabetologia. 2003 Apr;46(4):459-69
pubmed: 12687327
Food Chem Toxicol. 1997 Oct-Nov;35(10-11):1017-21
pubmed: 9463536
Environ Health. 2018 Aug 20;17(1):67
pubmed: 30126431
J Mol Endocrinol. 2018 Jul 13;:
pubmed: 30006341
Nat Med. 2004 Apr;10(4):355-61
pubmed: 15057233
Mol Cell Endocrinol. 2009 May 25;304(1-2):43-8
pubmed: 19433246
Environ Health Perspect. 2017 Jun 26;125(6):067015
pubmed: 28669934
Pediatr Obes. 2018 Sep;13(9):550-557
pubmed: 29700996
Pediatr Res. 2017 Sep;82(3):405-415
pubmed: 28426647
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Dec 1;860(1):106-12
pubmed: 17997365
Environ Int. 2016 Dec;97:56-67
pubmed: 27788374

Auteurs

Allison Kupsco (A)

Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University Medical Center, New York, NY, USA. Electronic address: Ak4181@cumc.columbia.edu.

Haotian Wu (H)

Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University Medical Center, New York, NY, USA.

Antonia M Calafat (AM)

National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Marianthi-Anna Kioumourtzoglou (MA)

Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University Medical Center, New York, NY, USA.

Marcela Tamayo-Ortiz (M)

Center for Research on Nutrition and Health, National Institute of Public Health, Cuernavaca, Morelos, Mexico; National Council of Science and Technology, Mexico.

Ivan Pantic (I)

National Institute of Perinatology, Mexico City, Mexico.

Alejandra Cantoral (A)

Center for Research on Nutrition and Health, National Institute of Public Health, Cuernavaca, Morelos, Mexico.

Maricruz Tolentino (M)

National Institute of Perinatology, Mexico City, Mexico.

Emily Oken (E)

Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.

Joseph M Braun (JM)

Department of Epidemiology, Brown University, Providence, RI, USA.

Andrea L Deierlein (AL)

Department of Epidemiology, School of Global Public Health, New York University, New York, NY, USA.

Robert O Wright (RO)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Martha M Téllez-Rojo (MM)

Center for Research on Nutrition and Health, National Institute of Public Health, Cuernavaca, Morelos, Mexico.

Andrea A Baccarelli (AA)

Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University Medical Center, New York, NY, USA.

Allan C Just (AC)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH